Vigabatrin and Corticotropin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vigabatrin (vigabatrin) and Corticotropin (corticotropin). Common drug interactions include drug ineffective among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Vigabatrin and Corticotropin. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Vigabatrin?

Vigabatrin has active ingredients of vigabatrin. eHealthMe is studying from 4,046 Vigabatrin users. Check the latest studies of Vigabatrin.

What is Corticotropin?

Corticotropin has active ingredients of corticotropin. eHealthMe is studying from 1,278 Corticotropin users. Check the latest studies of Corticotropin.



On Jul, 12, 2026

66 people who take Vigabatrin and Corticotropin together, and have interactions are studied.

Vigabatrin and Corticotropin drug interactions.

What are the common drug interactions of Vigabatrin and Corticotropin, by gender? *:

female:

  1. Drug ineffective
  2. Multiple-drug resistance
  3. Epidural lipomatosis (excessive accumulation of fat within the epidural space -brain)
  4. Paraplegia (paralysis of the legs and lower body)
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. Infantile spasms
  7. Nuclear magnetic resonance imaging brain
  8. Pain in extremity
  9. Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)
  10. Agitation (state of anxiety or nervous excitement)

male:

  1. Drug ineffective
  2. Hypertension (high blood pressure)
  3. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Multiple-drug resistance
  6. Cerebral disorder (brain disease)
  7. Encephalopathy (functioning of the brain is affected by some agent or condition)
  8. Decreased appetite
  9. Dehydration (dryness resulting from the removal of water)
  10. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)

What are the common drug interactions of Vigabatrin and Corticotropin, by age (0-1 to 60+)? *:

0-1:

  1. Drug ineffective
  2. Hypertension (high blood pressure)
  3. Agitation (state of anxiety or nervous excitement)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hypokalaemia (low potassium)
  7. Immunosuppression
  8. Irritability
  9. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  10. Proteinuria (presence of protein in the urine)

2-9:

  1. Drug ineffective
  2. Multiple-drug resistance
  3. Opisthotonus (a condition in which the body is held in an abnormal position)

10-19:

  1. Decreased appetite
  2. Dehydration (dryness resulting from the removal of water)
  3. Drug ineffective
  4. Fatigue (feeling of tiredness)
  5. Multiple-drug resistance
  6. Partial seizures (seizures which affect only a part of the brain at onset)
  7. Rash

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Infantile Spasms: 44 people, 66.67%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 12.12%
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 8 people, 12.12%
  4. Partial Seizures (seizures which affect only a part of the brain at onset): 7 people, 10.61%
  5. Myoclonic Epilepsy (type of epilepsy with quick little jerks of the arms, shoulder, or occasionally the legs): 5 people, 7.58%

* Approximation only. Some reports may have incomplete information.

Do you take Vigabatrin and Corticotropin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vigabatrin and Corticotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vigabatrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Corticotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vigabatrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Corticotropin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vigabatrin and corticotropin (the active ingredients of Vigabatrin and Corticotropin, respectively), and Vigabatrin and Corticotropin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: